Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$345K Buy
7,893
+4,372
+124% +$185K 0.01% 933
2026
Q2
$138K Buy
3,521
+1,455
+70% +$54K 0.01% 1562
2026
Q1
$82.7K Buy
2,066
+906
+78% +$42.9K ﹤0.01% 1813
2025
Q4
$52.2K Sell
1,160
-81
-7% -$3.75K ﹤0.01% 2056
2025
Q3
$55.4K Buy
1,241
+980
+375% +$46.9K ﹤0.01% 1913
2025
Q2
$12.5K Sell
261
-2,682
-91% -$117K ﹤0.01% 2695
2025
Q1
$118K Buy
2,943
+1,467
+99% +$61.7K 0.01% 1122
2024
Q4
$67.6K Buy
1,476
+930
+170% +$41.6K 0.01% 1406
2024
Q3
$25.6K Buy
546
+486
+810% +$22.2K ﹤0.01% 1953
2024
Q2
$2.55K Buy
60
+45
+300% +$1.97K ﹤0.01% 2815
2024
Q1
$645 Buy
15
+12
+400% +$547 ﹤0.01% 3050
2023
Q4
$131 Buy
+3
New +$128 ﹤0.01% 3135

Other funds holding QGEN

GAMMA Investing's QGEN Position: Q3 2026 in Review

GAMMA Investing increased its Qiagen (QGEN) stake by 124% in Q3 2026, buying an estimated $185K and bringing the position to 7,893 shares worth $345K. The position accounts for 0.01% of the portfolio, ranked #933.

GAMMA Investing first reported a position in QGEN in Q4 2023 and has held it in 12 quarters since. 8 funds tracked by Wall St. Rank hold QGEN as of Q3 2026.

  • GAMMA Investing held 7,893 shares of Qiagen worth $345K as of Q3 2026.
  • GAMMA Investing bought 4,372 Qiagen shares in Q3 2026, an estimated $185K.
  • Qiagen made up 0.01% of GAMMA Investing's portfolio in Q3 2026, its #933 holding.
  • GAMMA Investing first reported a position in Qiagen in Q4 2023 and has held it in 12 quarters since.
  • 8 funds tracked by Wall St. Rank held Qiagen as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.